Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shadi Salloum

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Hepatology|February 4, 2024
HIV coinfection exacerbates HBV-induced liver fibrogenesis through a HIF-1α- and TGF-β1-dependent pathwayMin Xu, Charlotte Warner, Xiaoqiong Duan, et al.
Journal of Hepatology|July 13, 2016
IQGAP2 is a novel interferon-alpha antiviral effector gene acting non-conventionally through the NF-κB pathwayCynthia Brisac, Shadi Salloum, Victor Yang, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Type I, II, and III interferon signatures correspond to COVID-19 disease severityMyung-Ho Kim, Shadi Salloum, Jeffrey Y Wang, et al.
The Journal of Infectious Diseases|September 1, 2021
Type I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 SeverityMyung-Ho Kim, Shadi Salloum, Jeffrey Y Wang, et al.
World Journal of Gastroenterology|December 27, 2016
Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis CEsperance A K Schaefer, James Meixiong, Christina Mark, et al.
Hepatology Communications|May 16, 2018
Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet-induced mouse model of nonalcoholic steatohepatitisAnnie J Kruger, Bryan C Fuchs, Ricard Masia, et al.
Hepatology Communications|June 17, 2022
Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signatureMyung-Ho Kim, Mi-Young Kim, Shadi Salloum, et al.
Hepatology (Baltimore, Md.)|August 18, 2016
Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell typesShadi Salloum, Jacinta A Holmes, Rohit Jindal, et al.
Journal of Virology|January 25, 2008
Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population levelChristoph Neumann-Haefelin, David N Frick, Jing Jing Wang, et al.
Journal of Virology|January 12, 2018
MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic PathwayXiaoqiong Duan, Shilin Li, Jacinta A Holmes, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Hepatology|February 4, 2024
HIV coinfection exacerbates HBV-induced liver fibrogenesis through a HIF-1α- and TGF-β1-dependent pathwayMin Xu, Charlotte Warner, Xiaoqiong Duan, et al.
Journal of Hepatology|July 13, 2016
IQGAP2 is a novel interferon-alpha antiviral effector gene acting non-conventionally through the NF-κB pathwayCynthia Brisac, Shadi Salloum, Victor Yang, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Type I, II, and III interferon signatures correspond to COVID-19 disease severityMyung-Ho Kim, Shadi Salloum, Jeffrey Y Wang, et al.
The Journal of Infectious Diseases|September 1, 2021
Type I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 SeverityMyung-Ho Kim, Shadi Salloum, Jeffrey Y Wang, et al.
World Journal of Gastroenterology|December 27, 2016
Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis CEsperance A K Schaefer, James Meixiong, Christina Mark, et al.
Hepatology Communications|May 16, 2018
Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet-induced mouse model of nonalcoholic steatohepatitisAnnie J Kruger, Bryan C Fuchs, Ricard Masia, et al.
Hepatology Communications|June 17, 2022
Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signatureMyung-Ho Kim, Mi-Young Kim, Shadi Salloum, et al.
Hepatology (Baltimore, Md.)|August 18, 2016
Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell typesShadi Salloum, Jacinta A Holmes, Rohit Jindal, et al.
Journal of Virology|January 25, 2008
Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population levelChristoph Neumann-Haefelin, David N Frick, Jing Jing Wang, et al.
Journal of Virology|January 12, 2018
MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic PathwayXiaoqiong Duan, Shilin Li, Jacinta A Holmes, et al.
Pageof 3